Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) have been given an average recommendation of “Hold” by the twenty-one ratings firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $15.13.

Several research firms recently weighed in on MDRX. Cantor Fitzgerald raised shares of Allscripts Healthcare Solutions from a “neutral” rating to an “overweight” rating and set a $12.00 target price for the company in a research note on Tuesday, August 15th. Royal Bank Of Canada began coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $17.00 target price for the company. Dougherty & Co reissued a “buy” rating and issued a $16.00 target price (up from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 3rd. Jefferies Group set a $17.00 target price on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research note on Friday, August 25th. Finally, Maxim Group reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd.

Allscripts Healthcare Solutions (MDRX) traded up $0.26 during trading hours on Friday, hitting $14.40. 2,142,512 shares of the company traded hands, compared to its average volume of 2,332,896. Allscripts Healthcare Solutions has a twelve month low of $10.19 and a twelve month high of $14.51. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20. The company has a market capitalization of $2,550.00, a PE ratio of 32.53, a PEG ratio of 2.49 and a beta of 1.34.

In other news, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $13.56, for a total value of $203,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP James Hewitt sold 36,796 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the sale, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The disclosure for this sale can be found here. In the last three months, insiders sold 71,796 shares of company stock valued at $992,992. 0.75% of the stock is currently owned by company insiders.

Several institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP bought a new stake in shares of Allscripts Healthcare Solutions in the third quarter valued at about $340,000. Neuberger Berman Group LLC boosted its position in shares of Allscripts Healthcare Solutions by 5.5% in the third quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock valued at $52,311,000 after acquiring an additional 190,158 shares during the period. California Public Employees Retirement System boosted its position in shares of Allscripts Healthcare Solutions by 5.6% in the third quarter. California Public Employees Retirement System now owns 506,028 shares of the software maker’s stock valued at $7,201,000 after acquiring an additional 26,928 shares during the period. Janney Montgomery Scott LLC bought a new stake in shares of Allscripts Healthcare Solutions in the third quarter valued at about $710,000. Finally, Janney Capital Management LLC boosted its position in shares of Allscripts Healthcare Solutions by 239.8% in the third quarter. Janney Capital Management LLC now owns 997,009 shares of the software maker’s stock valued at $14,187,000 after acquiring an additional 703,598 shares during the period.

COPYRIGHT VIOLATION NOTICE: “Allscripts Healthcare Solutions Inc (MDRX) Given Consensus Rating of “Hold” by Brokerages” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/08/allscripts-healthcare-solutions-inc-mdrx-given-consensus-rating-of-hold-by-brokerages.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.